Korean Venture Preps First Ovarian Cancer Cell Therapy
This article was originally published in PharmAsia News
Executive Summary
In another notable sign of progress in South Korea’s cell therapy space, a domestic research team has received approval to begin the country’s first clinical trial with an immunotherapy to treat epithelial ovarian cancer, which has the highest mortality rate among female cancer types and is usually discovered only at the advanced stage.